BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2024
  • September 2024
  • August 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Taysha Gene Therapies Inc. (TSHA)

1 post
Breakthrough in Alzheimers Treatment Biogen and Eisais Leqembi Wins UK Approval

Biotech NewsTaysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials

  • BioTech Health X
  • November 5, 2024
Taysha Gene Therapies, Inc. (TSHA), a leader in developing AAV-based gene therapies for severe central nervous system diseases,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Treace Medical (TMCI) Reports 11% Revenue Growth in Q3 2024
  • Taysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials
  • CEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer
  • Novartis Pioneers RNA Therapeutics with Borealis Biosciences for Kidney Diseases
  • Genentech’s Strategic Pivot: The Closure of Its Cancer Immunology Unit
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • November 6, 2024
    Treace Medical (TMCI) Reports 11% Revenue Growth in Q3 2024
    Coherus Presents Promising Phase I Results for Anti-CCR8 Antibody CHS-114 at ASCO 2024
    • November 5, 2024
    Taysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials
    Breakthrough in Alzheimers Treatment Biogen and Eisais Leqembi Wins UK Approval
    • September 16, 2024
    CEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer
    CEL-SCI Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer
    • August 22, 2024
    Novartis Pioneers RNA Therapeutics with Borealis Biosciences for Kidney Diseases
    Novartis Pioneers RNA Therapeutics with Borealis Biosciences for Kidney Diseases
    • August 22, 2024
    Genentech’s Strategic Pivot: The Closure of Its Cancer Immunology Unit
    Genentech Strategic Pivot The Closure of Its Cancer Immunology Unit
Recent Posts
  • Breakthrough in Alzheimers Treatment Biogen and Eisais Leqembi Wins UK Approval
    Breakthrough in Alzheimer’s Treatment: Biogen and Eisai’s Leqembi Wins UK Approval
    • August 22, 2024
  • Vera Therapeutics Atacicept Shows Promising Results in Phase 2b ORIGIN Trial for IgA Nephropathy
    Vera Therapeutics’ Atacicept Shows Promising Results in Phase 2b ORIGIN Trial for IgA Nephropathy
    • May 25, 2024
  • Ozempic Shows Lower Risk of Kidney and Heart Complications in Diabetic Patients
    Ozempic Shows Lower Risk of Kidney and Heart Complications in Diabetic Patients
    • May 24, 2024
Categories
  • BioTech CEO Interviews (5)
  • Biotech Info (1)
  • Biotech News (70)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top